Pfizer puts key Lipitor account up for grabs
NEW YORK: Pfizer, the world's largest drugs firm, is reviewing the global PR account for Lipitor, its best-selling drug.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>